Insannova Clinicals Private Limited

Insannova Clinicals Private Limited - research & development in Hyderabad, Telangana, India. Directors, charges & compliance details.
CIN U73100TG2012PTC082233 Incorporated 30 July 2012 ROC Hyderabad HQ Hyderabad, Telangana, India
Dissolved Under Section 59(8) Private Limited Company research and development
Revenue · FY 2021
₹3.63 Lakh
▼ 7% YoY
Net loss · FY 2021
₹6.91 Lakh
Net margin -190.1%
EBITDA · FY 2021
-₹6.85 Lakh
EBITDA margin -188.6%
Authorised capital
₹31 Lakh
Registered with MCA
Paid-up capital
₹30.16 Lakh
Issued & subscribed
Company age
14 yrs
Est. 2012
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered

About Insannova Clinicals Private Limited

Data last updated:

Insannova Clinicals Private Limited was a private limited company based in Hyderabad, Telangana, India. The company has been dissolved under section 59(8) as per MCA records and no longer exists as a legal entity. Any dealings with a dissolved entity carry legal and financial risk. It operated in the scientific research segment of the research and development sector. It was incorporated on 30 July 2012.

The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73100TG2012PTC082233. Its GSTIN is 36AADCI0412L1ZT (Telangana).

The company had an authorised share capital of ₹31 Lakh and a paid-up capital of ₹30.16 Lakh. It was led by directors including Madhavi Gaddampally Reddy and Aashritha Marepalli.

Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office was at Ghmc No. 24 – 239 Mig 239 Kphb Main Road Beside Remedy Hospital Kukatpally, Hyderabad, Telangana, India – 500072.

As per the financials filed for FY 2021, the company reported a revenue of ₹3.63 Lakh, a decline of 7% compared to the previous year. For the same year it recorded a net loss of ₹6.91 Lakh (net margin -190.1%) and EBITDA of -₹6.85 Lakh (EBITDA margin -188.6%). Revenue has declined at a compounded annual rate (CAGR) of 65% over three years and 21% over five years.

Company details

CIN U73100TG2012PTC082233
Registration Number 082233
Incorporation Date 30 July 2012
ROC Hyderabad
Listing Status Unlisted
Company Status Dissolved Under Section 59(8)
Compliance Status Active Compliant

CIN history

Insannova Clinicals has one previous CIN (Corporate Identification Number): U73100AP2012PTC082233. The current CIN is U73100TG2012PTC082233, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U73100TG2012PTC082233Current
U73100AP2012PTC082233Previous

Contact details

Insannova Clinicals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Ghmc No. 24 – 239 Mig 239 Kphb Main Road Beside Remedy Hospital Kukatpally, Hyderabad, Telangana, India – 500072
  • Industry
    Research & Development, Science Research

To see the full contact details of Insannova Clinicals Private Limited, buy the company report.

Comprehensive company report
Insannova Clinicals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Insannova Clinicals Private Limited

FY 2021 filings available

Insannova Clinicals Private Limited reported revenue of ₹3.63 Lakh (down 7% YoY) for FY 2021.

Revenue · FY 2021
₹3.63 Lakh ▼ 7%
Net loss · FY 2021
₹6.91 Lakh margin -190.1%
EBITDA · FY 2021
-₹6.85 Lakh margin -188.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 7%
3 years · compounded
▼ 65%
5 years · compounded
▼ 21%
EBITDA CAGR growth
1 year
▼ 86%
3 years · compounded
▼ 31%
5 years · compounded
▼ 21%

Revenue has declined at a compounded annual rate (CAGR) of 21% over five years, including a 7% fall in the latest year. EBITDA fell 86% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹6.85 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹6.91 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profitability
EBITDA Margin-188.6%
Net Profit Margin-190.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Insannova Clinicals Private Limited, buy the company report.

Board of directors of Insannova Clinicals Private Limited

Insannova Clinicals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Madhavi Gaddampally ReddyDirector30 Jul 201214 Years 3 MonthsAs last reported
Aashritha MarepalliDirector10 Aug 20206 Years 3 MonthsAs last reported
Satyanarayana SamatamDirector21 Aug 201412 Years 2 MonthsAs last reported

Auditor

Insannova Clinicals Private Limited is audited by S V RAGHUNATH & CO for the financial year 2017.

Auditor firmFinancial yearFirm registration number
S V RAGHUNATH & COFY 2017013530S

Shareholding

The shareholding of Insannova Clinicals Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016FY 2015
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Insannova Clinicals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Insannova Clinicals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Insannova Clinicals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36AADCI0412L1ZTTelanganaActive05 Aug 2017

To see the full GST registrations and return filing status of Insannova Clinicals Private Limited, buy the company report.

Recent activity

Insannova Clinicals Private Limited has 5 board changes on record since 2012: 3 appointments and 2 cessations. The latest: Aashritha Marepalli ceased to be Additional Director on 31 Dec 2020.

AGM
Insannova Clinicals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records.
Filing
Insannova Clinicals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Hyderabad.
Ceased
Aashritha Marepalli ceased to be Additional Director.
Appointed
Aashritha Marepalli was appointed as Director.
Ceased
Hanumantha Rao Marepalli ceased to be Director.
Appointed
Satyanarayana Samatam was appointed as Director.
Appointed
Madhavi Gaddampally Reddy was appointed as Director.
Incorporation
30 Jul 2012
Insannova Clinicals Private Limited was registered on 30 Jul 2012 with Roc Hyderabad & aged 14 years 3 months as per MCA records.

Frequently asked questions

Insannova Clinicals has been "Dissolved Under Section 59(8)" as per MCA records. The company has ceased to exist as a legal entity. Any contracts or dealings with a dissolved entity may be legally unenforceable.

Insannova Clinicals was a private limited company based in Hyderabad, Telangana, India. The company worked in science research, within the research and development industry. It was incorporated on 30 July 2012 and is registered under CIN U73100TG2012PTC082233. The company is recorded as dissolved under section 59(8) in MCA records and no longer exists as a legal entity.

Insannova Clinicals was incorporated on 30 July 2012. It is registered with the Registrar of Companies, Hyderabad.

Insannova Clinicals had 3 directors:

The CIN (Corporate Identification Number) of Insannova Clinicals is U73100TG2012PTC082233. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of Insannova Clinicals is at Ghmc No. 24 – 239 Mig 239 Kphb Main Road Beside Remedy Hospital Kukatpally, Hyderabad, Telangana, India – 500072.

The latest financial statements of Insannova Clinicals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from 2015 are in the company report.

The GSTIN of Insannova Clinicals is 36AADCI0412L1ZT, registered in Telangana.

Insannova Clinicals operated in the research and development industry, in the science research segment.

Aashritha Marepalli ceased to be Additional Director on 31 Dec 2020. Aashritha Marepalli was appointed as Director on 10 Aug 2020. Hanumantha Rao Marepalli ceased to be Director on 09 Apr 2020. Insannova Clinicals has 5 board changes on record in total.